The short answer
Expanded access, or compassionate use, is a way for a person with a serious illness to try an unapproved treatment outside a clinical trial when no other options remain and they cannot join a trial.
Expanded access lets some patients use an unapproved treatment outside a trial.
It is also called compassionate use.
It is meant for serious conditions with no good alternatives.
It usually requires that the person cannot join a suitable trial.
Choose how you want to understand this
The full explanation.
A path outside a trial
Expanded access — often called compassionate use — is a way for a person with a serious illness to try a treatment that is not yet approved, without joining a clinical trial. It exists for situations where the usual options have run out.
Who it is for
Expanded access is generally meant for people with a serious or life-threatening condition who cannot take part in a suitable clinical trial and who have no satisfactory approved treatment left to try. It is not a substitute for a trial when one is available.
Who must agree
Three parties have to line up. The treating doctor must request it and be willing to oversee the treatment. The company that makes the investigational treatment must agree to provide it — they are not required to. And the FDA must authorize the use.
How it differs from a trial
A clinical trial is a study designed to answer research questions under a controlled plan. Expanded access is about giving a treatment to a patient who needs it, not primarily about collecting research data. If you think it might apply to you, your oncologist is the person to start the conversation with.
Words to know
Tap any term to see what it means.
Common questions
▸What is expanded access?
Expanded access, sometimes called compassionate use, is a pathway that allows a person with a serious illness to receive an investigational treatment outside a clinical trial when they have no comparable options.
▸Who qualifies?
It is generally for people with a serious or life-threatening condition who cannot take part in a clinical trial and have no satisfactory approved treatment available.
▸Who has to agree?
The treating doctor must request it, the company that makes the treatment must agree to provide it, and the FDA must authorize it.
▸Is it the same as a clinical trial?
No. A trial is a study designed to answer research questions. Expanded access is about providing treatment to a patient, not primarily about gathering research data.
Test your knowledge
0 of 5 answered
This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.
How this page was created
Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.
Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.